A method is described to determine the 8-methoxypsoralen (8 -MOP) concentration in vivo in the skin by means of high-performance liquid chromatography (HPLC). Skin and blood samples were taken from 80 rats at specific intervals after oral administration of [ 3 H]8-MOP. The pharmacokinetic results obtained for the skin levels were compared to the blood levels. In a ddition, liquid scintillation counting (LSC) was done on all the samples to compare the concentrations of 8-MOP plus metabolites to the concentrations of 8 -MOP alone.
A method is described to determine the 8-methoxypsoralen (8 -MOP) concentration in vivo in the skin by means of high-performance liquid chromatography (HPLC). Skin and blood samples were taken from 80 rats at specific intervals after oral administration of [ 3 H]8-MOP. The pharmacokinetic results obtained for the skin levels were compared to the blood levels. In a ddition, liquid scintillation counting (LSC) was done on all the samples to compare the concentrations of 8-MOP plus metabolites to the concentrations of 8 -MOP alone.
There was a good correlation between the 8-MOP skin and blood levels. The values obtained with LSC were higher in function of time than the corresponding values obtained by HPLC, which indicates the presence of metabolites in both the skin and the blood. No statistically significant diffe rence in the time of peaking was noted for the skin and blood levels. The blood le vels seem to be a good parameter for the 8-MOP skin concentration.
The most suitable time for t he UV A (long-wave ultraviolet radiation) exposure seems to be when t he UV A sensitivity of t he skin is at a maximum so t hat t he exposure t ime may be as short as possible. However, t here can be considerable interindividual differences in maximal UV A sensit ivity [1] as well as high interindividual variability in t he 8-methoxypsoralen (8-MOP) serum levels [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . In addition , there is a rather high intraindividual variability of 8-MOP plasma levels [1 3] .
A poor response to P UV A (psoralen plus UV A) t herapy may be due to low 8-MOP serum levels at t he t ime of the UVA irradiation [8] . Nevert heless, good results have been reported in some cases wi t h very low serum levels [2] . This might be explained by the lack of a positive correlat ion between the blood and t he skin concentrations.
In vit ro, t he human epidermis is able to bind and concent rate 8-MOP without t he influence of UV A [1 4), which could lead to high epidermal 8-MOP levels and a prolonged rediffusie n t ime of t he drug from t he skin . This may result in retention of skin photosensitivity at even markedly reduced serum levels. Suction blister fluid studies suggest that the reduction of 8-MOP concentration is slower in t he skin t han in t he serum [15] . Thus, t he 8-MOP plasma concent rat ion does not always seem t o be a reliable parameter for t he prediction of treatment results [16] . A more reliable parameter would be t he 8-MOP skin concentration . Therefore, we set out to develop a method for Ma nuscript rece ived Ja nua ry 14, 1983; accepted for publicatio n April 25, 1983. This work was supported by Gran t OT/ VIII/43, Onderzoeks fonds, Katholieke Universite it Leuve n.
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Abbreviations: HPLC: high-performance liquid chromatography LSC: liquid scin till ation coun t ing 8-MOP: 8-methoxypsoralen, methoxsalen P UV A: pso ralen plus UV A UV A: long-wave ul trav iolet radi ation 8-MOP skin determination and to study t he pharmacokinetics of 8-MOP in t he skin as compared to t he blood levels. We went on to compare t hese results obtained wit h high-perfor mance liquid chromatography (HPLC) to t he levels obtained by liquid scint illation count ing (LSC), measuring not only t he 8-MOP but also its metabolites.
MATERIALS AND METHODS

A nimals
Eighty shaven female Psd:WIST out bred rats weighing about 200 g were each orally administered 2 mg of [ 3 H]8-MO P in oil (0.5 ml; 71.20 11 Ci). At regula r intervals (0.5, 1.0, 1.5, 2.0, 2.5, 3.5, 6.0, and 10 h ), 10 rats were decapitated to co llect blood a nd skin samples. After adding 5 drops of heparin solut ion, one blood sample of 0.5 ml was set aside fo r HPLC and two 0.5-ml blood samp les for LSC. T he skin samples were ta ken from t he bac ks of t he animals, collected in vials, and weighed. Two samples were set as ide for H P LC and 6 for LSC. This was done for eac h animal.
Drug
An 8-mCi sample of 8-methoxy-[G-3 H]pso ralen was obtained from Amersham In tern ation al Ltd , Am ersham, U. K. It was puri fied with HPLC [1 7] on a 23 x 2.5 em column of 15-l'm silicagel particles in methylene chloride. Elution was carried out wit h methylene chloride co ntaining 0.2% of methano l at 15 mljmin.
8-MOP S l~in and Blood Levels
For eac h rat, 2 skin samples of about 100 mg each co nsisting of epidermis, dermis, and subcutis were homoge nized and extracted with a mi xture of toluene and n-hexane (60:40) follow ing t he addi tion of 100 ng of 5-MO P as t he inte rnal standard. T he organic phases were sepa rated by centrifugation a nd t ra nsferred into conical tubes. After evaporation of t he solvent, t he residues we re redissolved in 40 J.Ll of methylene chloride and examined by H P LC. A silicagel column (S i60, 7 11m ) was used. The mobile phase consisted of a mix ture of methylene chl oride: n-hexa ne: ethanol (100:20:0.1) at 2 ml / min. A UV detector at 254 nm was used for the detection. The co ncentrations were calculated by means of a calibration graph prepared by addin g know n amou nts of 8-MO P a long wit h 100 ng of in ternal standard to dru g-free ski n samples.
The other 6 sampl es from eac h rat we re used to measure total radioactivity by means of LSC using [ 3 H]n -hexadecane [18] as the internal standa rd. For eac h rat, 1 blood sampl e was used for H P LC and 2 fo r LSC. T he blood samples for HP LC we re extracted according to a method we have desc ribed elsewhere [19] .
RESULTS AND DISCUSSION
The mean values fo r t he 8-MOP skin levels as measured wi t h HPLC and LSC are give n in Figs 1 and 2. There was no statistically significant difference between t he different mean values 0.5-2.0 h after oral intake, but t he differences were significant t hereafter ( p < 0.025 after 2.5 h; p < 0.01 after 3.5 h; p < 0.005 after 6 h; p < 0.005 afte r 10 h). The LSC values were about 50 % higher at 3.5 h t han t he HPLC levels. T hese differences may obviously be explained by t he presence of formed metabolites not measured by H P LC.
The 6 skin samples from each rat for LSC were taken from diffe rent areas on t he back and often showed significant diffe rences in radioactivity, indicating a diffe rent 8-MOP concentration depending on t he a rea. This might be because of di ffe rences m t he fat content of t he skin at diffe rent places. Indeed, 8- MOP is liposoluble and has a low degree of solubility in water. This is illustrated by the fact that a fatty meal may enhance the resorption of 8-MOP [20] . It has also been demonstrated by whole-body autoradiography that UV A irradiation can produce an increase in the amount of radioactivity in the subcutis, particularly in the loose connective tissue layers and in the hair follicles [21] . The subcutis accumulation was seen after a high 8-MOP and radiation dose. No higher radioactivity concentrat ions have been found in the subcutis after UV A exposure using therapeutic doses of 8-MOP [22] . Vol. 81, No.4 With skin samples from psoriasis patients but under in vitro conditions, a higher label incorporation has been noted in the upper layers of the epidermis after UV A irradiation. Indeed, parakeratotic cells show a greater degree of photobinding than the cells of the basal layer [23] . Figures 1 and 2 also show the mean 8-MOP blood levels as a function of time as determined by HPLC and by LSC. There was no significant difference (p > 0.2) between the different mean values 0.5-2.0 h after oral intake for t he 8-MOP as . measured by HPLC and by LSC. However, after 2 h the LSC levels were significantly higher than the HPLC values for the 8-MOP alone (p < 0.05 after 2.5 h; p < 0.01 after 3.5 h; p < 0.0005 after 6 h; p < 0.0005 after 10 h). After 2.5 h, the difference was about 25 %. In contrast to the skin samples, there was no significant difference between the two samples used for LSC each time .
Because 8-MOP is rapidly metabolized, metabolites appear in the plasma shortly after oral administration. A reason for the relatively long elimination time of the 8-MOP metabolites may be a rediffusion of the radioactivity from the tissues into the blood [24] .
Comparison Between 8-MOP Skin and Blood Levels
On the basis of Figs 1 and 2, there seems to be a good correlation between the 8-MOP skin and ' blood levels as determined by both HPLC and LSC. Only after 1.5 h with LSC and after 2 h with HPLC were significant differences noted between the blood and skin levels (p < 0.05). The fact that the skin levels are then higher than the blood levels might account for the retention of skin photosensitivity at even markedly reduced serum levels. This concurs with the results of other experiments and suggests that the skin may act as a deep compartment [25] .
The difference between LSC and HPLC is higher for the skin samples than for the blood samples. This could be attributed to a difference in pharmacokinetics between the skin and the blood for 8-MOP and its metabolites. Another explanation could be significant metabolization.in the skin.
Determination of the 8-MOP blood levels seems to be a good parameter for the determination of the skin levels, although our experiments do not allow us to conclude that the time of peaking is exactly the same for both the skin and the blood. However, the similarity of the curves in Figs 1 and 2 suggests that there is not a major difference.
